nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—Caffeine—RYR1—kidney cancer	0.0124	0.61	CrCbGaD
Pentoxifylline—CYP1A2—urine—kidney cancer	0.0105	0.0901	CbGeAlD
Pentoxifylline—NT5E—nephron tubule—kidney cancer	0.0101	0.0868	CbGeAlD
Pentoxifylline—NT5E—renal system—kidney cancer	0.00922	0.0789	CbGeAlD
Pentoxifylline—NT5E—kidney—kidney cancer	0.00891	0.0763	CbGeAlD
Pentoxifylline—NT5E—cortex of kidney—kidney cancer	0.00868	0.0743	CbGeAlD
Pentoxifylline—NT5E—gonad—kidney cancer	0.00826	0.0707	CbGeAlD
Pentoxifylline—NT5E—cardiac atrium—kidney cancer	0.00825	0.0707	CbGeAlD
Pentoxifylline—PDE5A—renal system—kidney cancer	0.00598	0.0512	CbGeAlD
Pentoxifylline—Caffeine—PIK3CA—kidney cancer	0.00591	0.291	CrCbGaD
Pentoxifylline—ADORA2A—gonad—kidney cancer	0.00589	0.0504	CbGeAlD
Pentoxifylline—ADORA1—renal system—kidney cancer	0.00567	0.0485	CbGeAlD
Pentoxifylline—ADORA1—kidney—kidney cancer	0.00548	0.0469	CbGeAlD
Pentoxifylline—PDE5A—gonad—kidney cancer	0.00536	0.0459	CbGeAlD
Pentoxifylline—ADORA1—cortex of kidney—kidney cancer	0.00534	0.0457	CbGeAlD
Pentoxifylline—ADORA1—cardiac atrium—kidney cancer	0.00508	0.0435	CbGeAlD
Pentoxifylline—PDE4B—cortex of kidney—kidney cancer	0.00395	0.0338	CbGeAlD
Pentoxifylline—PDE4B—gonad—kidney cancer	0.00376	0.0322	CbGeAlD
Pentoxifylline—PDE4B—cardiac atrium—kidney cancer	0.00376	0.0322	CbGeAlD
Pentoxifylline—CYP1A2—renal system—kidney cancer	0.00258	0.0221	CbGeAlD
Pentoxifylline—Caffeine—CYP1A1—kidney cancer	0.0013	0.064	CrCbGaD
Pentoxifylline—Caffeine—ABCB1—kidney cancer	0.000689	0.034	CrCbGaD
Pentoxifylline—Hypersensitivity—Sorafenib—kidney cancer	0.000602	0.00103	CcSEcCtD
Pentoxifylline—Insomnia—Vincristine—kidney cancer	0.000601	0.00103	CcSEcCtD
Pentoxifylline—Anorexia—Gemcitabine—kidney cancer	0.000601	0.00103	CcSEcCtD
Pentoxifylline—Vomiting—Vinblastine—kidney cancer	0.0006	0.00103	CcSEcCtD
Pentoxifylline—Dizziness—Erlotinib—kidney cancer	0.0006	0.00103	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Paclitaxel—kidney cancer	0.0006	0.00103	CcSEcCtD
Pentoxifylline—Vomiting—Everolimus—kidney cancer	0.000598	0.00103	CcSEcCtD
Pentoxifylline—Anaemia—Paclitaxel—kidney cancer	0.000598	0.00103	CcSEcCtD
Pentoxifylline—Agitation—Paclitaxel—kidney cancer	0.000594	0.00102	CcSEcCtD
Pentoxifylline—Rash—Everolimus—kidney cancer	0.000593	0.00102	CcSEcCtD
Pentoxifylline—Dermatitis—Everolimus—kidney cancer	0.000593	0.00102	CcSEcCtD
Pentoxifylline—Headache—Vinblastine—kidney cancer	0.000592	0.00102	CcSEcCtD
Pentoxifylline—Angioedema—Paclitaxel—kidney cancer	0.000591	0.00101	CcSEcCtD
Pentoxifylline—Purpura—Doxorubicin—kidney cancer	0.000589	0.00101	CcSEcCtD
Pentoxifylline—Headache—Everolimus—kidney cancer	0.000589	0.00101	CcSEcCtD
Pentoxifylline—Hypotension—Gemcitabine—kidney cancer	0.000589	0.00101	CcSEcCtD
Pentoxifylline—Abdominal pain—Dactinomycin—kidney cancer	0.000588	0.00101	CcSEcCtD
Pentoxifylline—Body temperature increased—Dactinomycin—kidney cancer	0.000588	0.00101	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000587	0.00101	CcSEcCtD
Pentoxifylline—Asthenia—Sorafenib—kidney cancer	0.000586	0.00101	CcSEcCtD
Pentoxifylline—Malaise—Paclitaxel—kidney cancer	0.000583	0.001	CcSEcCtD
Pentoxifylline—Leukopenia—Paclitaxel—kidney cancer	0.000579	0.000994	CcSEcCtD
Pentoxifylline—Hypersensitivity—Sunitinib—kidney cancer	0.000579	0.000994	CcSEcCtD
Pentoxifylline—Decreased appetite—Vincristine—kidney cancer	0.000578	0.000992	CcSEcCtD
Pentoxifylline—Pruritus—Sorafenib—kidney cancer	0.000578	0.000992	CcSEcCtD
Pentoxifylline—Vomiting—Erlotinib—kidney cancer	0.000577	0.000991	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000574	0.000986	CcSEcCtD
Pentoxifylline—Rash—Erlotinib—kidney cancer	0.000572	0.000983	CcSEcCtD
Pentoxifylline—Dermatitis—Erlotinib—kidney cancer	0.000572	0.000982	CcSEcCtD
Pentoxifylline—Palpitations—Paclitaxel—kidney cancer	0.000572	0.000982	CcSEcCtD
Pentoxifylline—Insomnia—Gemcitabine—kidney cancer	0.00057	0.000979	CcSEcCtD
Pentoxifylline—Headache—Erlotinib—kidney cancer	0.000569	0.000977	CcSEcCtD
Pentoxifylline—Constipation—Vincristine—kidney cancer	0.000568	0.000976	CcSEcCtD
Pentoxifylline—Flushing—Capecitabine—kidney cancer	0.000566	0.000972	CcSEcCtD
Pentoxifylline—Asthenia—Sunitinib—kidney cancer	0.000564	0.000968	CcSEcCtD
Pentoxifylline—Dyspnoea—Gemcitabine—kidney cancer	0.000562	0.000965	CcSEcCtD
Pentoxifylline—Nausea—Vinblastine—kidney cancer	0.000561	0.000963	CcSEcCtD
Pentoxifylline—Somnolence—Gemcitabine—kidney cancer	0.000561	0.000963	CcSEcCtD
Pentoxifylline—Convulsion—Paclitaxel—kidney cancer	0.00056	0.000962	CcSEcCtD
Pentoxifylline—Nausea—Everolimus—kidney cancer	0.000559	0.00096	CcSEcCtD
Pentoxifylline—Diarrhoea—Sorafenib—kidney cancer	0.000559	0.000959	CcSEcCtD
Pentoxifylline—Hypertension—Paclitaxel—kidney cancer	0.000558	0.000959	CcSEcCtD
Pentoxifylline—Pruritus—Sunitinib—kidney cancer	0.000556	0.000955	CcSEcCtD
Pentoxifylline—Immune system disorder—Capecitabine—kidney cancer	0.000551	0.000946	CcSEcCtD
Pentoxifylline—Chest pain—Paclitaxel—kidney cancer	0.000551	0.000946	CcSEcCtD
Pentoxifylline—Myalgia—Paclitaxel—kidney cancer	0.000551	0.000946	CcSEcCtD
Pentoxifylline—Anxiety—Paclitaxel—kidney cancer	0.000549	0.000942	CcSEcCtD
Pentoxifylline—Decreased appetite—Gemcitabine—kidney cancer	0.000548	0.000941	CcSEcCtD
Pentoxifylline—Hypersensitivity—Dactinomycin—kidney cancer	0.000548	0.000941	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000547	0.000939	CcSEcCtD
Pentoxifylline—Arrhythmia—Capecitabine—kidney cancer	0.000545	0.000935	CcSEcCtD
Pentoxifylline—Discomfort—Paclitaxel—kidney cancer	0.000544	0.000934	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Vincristine—kidney cancer	0.000543	0.000933	CcSEcCtD
Pentoxifylline—Dizziness—Sorafenib—kidney cancer	0.00054	0.000927	CcSEcCtD
Pentoxifylline—Constipation—Gemcitabine—kidney cancer	0.000539	0.000926	CcSEcCtD
Pentoxifylline—Nausea—Erlotinib—kidney cancer	0.000539	0.000926	CcSEcCtD
Pentoxifylline—Dry mouth—Paclitaxel—kidney cancer	0.000539	0.000925	CcSEcCtD
Pentoxifylline—Diarrhoea—Sunitinib—kidney cancer	0.000538	0.000923	CcSEcCtD
Pentoxifylline—Asthenia—Dactinomycin—kidney cancer	0.000534	0.000917	CcSEcCtD
Pentoxifylline—Confusional state—Paclitaxel—kidney cancer	0.000532	0.000914	CcSEcCtD
Pentoxifylline—Erythema—Capecitabine—kidney cancer	0.000531	0.000912	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Paclitaxel—kidney cancer	0.000528	0.000907	CcSEcCtD
Pentoxifylline—Oedema—Paclitaxel—kidney cancer	0.000528	0.000907	CcSEcCtD
Pentoxifylline—Abdominal pain—Vincristine—kidney cancer	0.000525	0.000902	CcSEcCtD
Pentoxifylline—Body temperature increased—Vincristine—kidney cancer	0.000525	0.000902	CcSEcCtD
Pentoxifylline—Infection—Paclitaxel—kidney cancer	0.000524	0.000901	CcSEcCtD
Pentoxifylline—Flatulence—Capecitabine—kidney cancer	0.000523	0.000898	CcSEcCtD
Pentoxifylline—Dysgeusia—Capecitabine—kidney cancer	0.00052	0.000893	CcSEcCtD
Pentoxifylline—Dizziness—Sunitinib—kidney cancer	0.00052	0.000892	CcSEcCtD
Pentoxifylline—Feeling abnormal—Gemcitabine—kidney cancer	0.00052	0.000892	CcSEcCtD
Pentoxifylline—Shock—Paclitaxel—kidney cancer	0.000519	0.000892	CcSEcCtD
Pentoxifylline—Vomiting—Sorafenib—kidney cancer	0.000519	0.000892	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Paclitaxel—kidney cancer	0.000517	0.000888	CcSEcCtD
Pentoxifylline—Tachycardia—Paclitaxel—kidney cancer	0.000515	0.000885	CcSEcCtD
Pentoxifylline—Rash—Sorafenib—kidney cancer	0.000515	0.000884	CcSEcCtD
Pentoxifylline—Dermatitis—Sorafenib—kidney cancer	0.000514	0.000883	CcSEcCtD
Pentoxifylline—Back pain—Capecitabine—kidney cancer	0.000513	0.000882	CcSEcCtD
Pentoxifylline—Skin disorder—Paclitaxel—kidney cancer	0.000513	0.000881	CcSEcCtD
Pentoxifylline—Headache—Sorafenib—kidney cancer	0.000512	0.000879	CcSEcCtD
Pentoxifylline—Muscle spasms—Capecitabine—kidney cancer	0.00051	0.000876	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Paclitaxel—kidney cancer	0.00051	0.000876	CcSEcCtD
Pentoxifylline—Diarrhoea—Dactinomycin—kidney cancer	0.000509	0.000874	CcSEcCtD
Pentoxifylline—Anorexia—Paclitaxel—kidney cancer	0.000503	0.000864	CcSEcCtD
Pentoxifylline—Vision blurred—Capecitabine—kidney cancer	0.0005	0.000859	CcSEcCtD
Pentoxifylline—Vomiting—Sunitinib—kidney cancer	0.0005	0.000858	CcSEcCtD
Pentoxifylline—Body temperature increased—Gemcitabine—kidney cancer	0.000498	0.000856	CcSEcCtD
Pentoxifylline—Tremor—Capecitabine—kidney cancer	0.000497	0.000854	CcSEcCtD
Pentoxifylline—Rash—Sunitinib—kidney cancer	0.000495	0.000851	CcSEcCtD
Pentoxifylline—Dermatitis—Sunitinib—kidney cancer	0.000495	0.00085	CcSEcCtD
Pentoxifylline—Abdominal distension—Doxorubicin—kidney cancer	0.000494	0.000849	CcSEcCtD
Pentoxifylline—Hypotension—Paclitaxel—kidney cancer	0.000493	0.000847	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Capecitabine—kidney cancer	0.000493	0.000846	CcSEcCtD
Pentoxifylline—Headache—Sunitinib—kidney cancer	0.000492	0.000845	CcSEcCtD
Pentoxifylline—Anaemia—Capecitabine—kidney cancer	0.000491	0.000842	CcSEcCtD
Pentoxifylline—Hypersensitivity—Vincristine—kidney cancer	0.00049	0.000841	CcSEcCtD
Pentoxifylline—Nausea—Sorafenib—kidney cancer	0.000485	0.000833	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000481	0.000826	CcSEcCtD
Pentoxifylline—Malaise—Capecitabine—kidney cancer	0.000479	0.000822	CcSEcCtD
Pentoxifylline—Angina pectoris—Doxorubicin—kidney cancer	0.000478	0.000821	CcSEcCtD
Pentoxifylline—Insomnia—Paclitaxel—kidney cancer	0.000477	0.00082	CcSEcCtD
Pentoxifylline—Asthenia—Vincristine—kidney cancer	0.000477	0.000819	CcSEcCtD
Pentoxifylline—Leukopenia—Capecitabine—kidney cancer	0.000475	0.000816	CcSEcCtD
Pentoxifylline—Vomiting—Dactinomycin—kidney cancer	0.000473	0.000812	CcSEcCtD
Pentoxifylline—Dyspnoea—Paclitaxel—kidney cancer	0.000471	0.000808	CcSEcCtD
Pentoxifylline—Somnolence—Paclitaxel—kidney cancer	0.000469	0.000806	CcSEcCtD
Pentoxifylline—Palpitations—Capecitabine—kidney cancer	0.000469	0.000806	CcSEcCtD
Pentoxifylline—Rash—Dactinomycin—kidney cancer	0.000469	0.000805	CcSEcCtD
Pentoxifylline—Nausea—Sunitinib—kidney cancer	0.000467	0.000802	CcSEcCtD
Pentoxifylline—Pancytopenia—Doxorubicin—kidney cancer	0.000466	0.000801	CcSEcCtD
Pentoxifylline—Dyspepsia—Paclitaxel—kidney cancer	0.000465	0.000798	CcSEcCtD
Pentoxifylline—Decreased appetite—Paclitaxel—kidney cancer	0.000459	0.000788	CcSEcCtD
Pentoxifylline—Hypertension—Capecitabine—kidney cancer	0.000458	0.000787	CcSEcCtD
Pentoxifylline—Diarrhoea—Vincristine—kidney cancer	0.000455	0.000781	CcSEcCtD
Pentoxifylline—Asthenia—Gemcitabine—kidney cancer	0.000452	0.000777	CcSEcCtD
Pentoxifylline—Chest pain—Capecitabine—kidney cancer	0.000452	0.000776	CcSEcCtD
Pentoxifylline—Myalgia—Capecitabine—kidney cancer	0.000452	0.000776	CcSEcCtD
Pentoxifylline—Constipation—Paclitaxel—kidney cancer	0.000451	0.000775	CcSEcCtD
Pentoxifylline—Anxiety—Capecitabine—kidney cancer	0.00045	0.000773	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000449	0.000771	CcSEcCtD
Pentoxifylline—Discomfort—Capecitabine—kidney cancer	0.000446	0.000767	CcSEcCtD
Pentoxifylline—Pruritus—Gemcitabine—kidney cancer	0.000446	0.000766	CcSEcCtD
Pentoxifylline—Dry mouth—Capecitabine—kidney cancer	0.000442	0.000759	CcSEcCtD
Pentoxifylline—Nausea—Dactinomycin—kidney cancer	0.000442	0.000759	CcSEcCtD
Pentoxifylline—Dizziness—Vincristine—kidney cancer	0.00044	0.000755	CcSEcCtD
Pentoxifylline—Drowsiness—Doxorubicin—kidney cancer	0.000438	0.000752	CcSEcCtD
Pentoxifylline—Infestation NOS—Doxorubicin—kidney cancer	0.000438	0.000752	CcSEcCtD
Pentoxifylline—Infestation—Doxorubicin—kidney cancer	0.000438	0.000752	CcSEcCtD
Pentoxifylline—Confusional state—Capecitabine—kidney cancer	0.000437	0.00075	CcSEcCtD
Pentoxifylline—Feeling abnormal—Paclitaxel—kidney cancer	0.000435	0.000747	CcSEcCtD
Pentoxifylline—Oedema—Capecitabine—kidney cancer	0.000433	0.000744	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000432	0.000741	CcSEcCtD
Pentoxifylline—Diarrhoea—Gemcitabine—kidney cancer	0.000431	0.000741	CcSEcCtD
Pentoxifylline—Infection—Capecitabine—kidney cancer	0.00043	0.000739	CcSEcCtD
Pentoxifylline—Jaundice—Doxorubicin—kidney cancer	0.000427	0.000733	CcSEcCtD
Pentoxifylline—Shock—Capecitabine—kidney cancer	0.000426	0.000732	CcSEcCtD
Pentoxifylline—Conjunctivitis—Doxorubicin—kidney cancer	0.000426	0.000731	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Capecitabine—kidney cancer	0.000424	0.000728	CcSEcCtD
Pentoxifylline—Tachycardia—Capecitabine—kidney cancer	0.000423	0.000726	CcSEcCtD
Pentoxifylline—Vomiting—Vincristine—kidney cancer	0.000423	0.000726	CcSEcCtD
Pentoxifylline—Skin disorder—Capecitabine—kidney cancer	0.000421	0.000723	CcSEcCtD
Pentoxifylline—Sweating—Doxorubicin—kidney cancer	0.00042	0.000721	CcSEcCtD
Pentoxifylline—Urticaria—Paclitaxel—kidney cancer	0.000419	0.00072	CcSEcCtD
Pentoxifylline—Rash—Vincristine—kidney cancer	0.000419	0.00072	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Capecitabine—kidney cancer	0.000419	0.000719	CcSEcCtD
Pentoxifylline—Dermatitis—Vincristine—kidney cancer	0.000419	0.000719	CcSEcCtD
Pentoxifylline—Abdominal pain—Paclitaxel—kidney cancer	0.000417	0.000717	CcSEcCtD
Pentoxifylline—Body temperature increased—Paclitaxel—kidney cancer	0.000417	0.000717	CcSEcCtD
Pentoxifylline—Headache—Vincristine—kidney cancer	0.000416	0.000715	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000414	0.000711	CcSEcCtD
Pentoxifylline—Epistaxis—Doxorubicin—kidney cancer	0.000413	0.000709	CcSEcCtD
Pentoxifylline—Anorexia—Capecitabine—kidney cancer	0.000413	0.000709	CcSEcCtD
Pentoxifylline—Hypotension—Capecitabine—kidney cancer	0.000405	0.000695	CcSEcCtD
Pentoxifylline—Vomiting—Gemcitabine—kidney cancer	0.000401	0.000688	CcSEcCtD
Pentoxifylline—Rash—Gemcitabine—kidney cancer	0.000398	0.000683	CcSEcCtD
Pentoxifylline—Dermatitis—Gemcitabine—kidney cancer	0.000397	0.000682	CcSEcCtD
Pentoxifylline—Haemoglobin—Doxorubicin—kidney cancer	0.000395	0.000678	CcSEcCtD
Pentoxifylline—Headache—Gemcitabine—kidney cancer	0.000395	0.000678	CcSEcCtD
Pentoxifylline—Nausea—Vincristine—kidney cancer	0.000395	0.000678	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000395	0.000678	CcSEcCtD
Pentoxifylline—Haemorrhage—Doxorubicin—kidney cancer	0.000393	0.000675	CcSEcCtD
Pentoxifylline—Hepatitis—Doxorubicin—kidney cancer	0.000393	0.000675	CcSEcCtD
Pentoxifylline—Insomnia—Capecitabine—kidney cancer	0.000392	0.000673	CcSEcCtD
Pentoxifylline—Hypersensitivity—Paclitaxel—kidney cancer	0.000389	0.000668	CcSEcCtD
Pentoxifylline—Dyspnoea—Capecitabine—kidney cancer	0.000386	0.000663	CcSEcCtD
Pentoxifylline—Dyspepsia—Capecitabine—kidney cancer	0.000381	0.000655	CcSEcCtD
Pentoxifylline—Asthenia—Paclitaxel—kidney cancer	0.000379	0.00065	CcSEcCtD
Pentoxifylline—Decreased appetite—Capecitabine—kidney cancer	0.000377	0.000647	CcSEcCtD
Pentoxifylline—Nausea—Gemcitabine—kidney cancer	0.000375	0.000643	CcSEcCtD
Pentoxifylline—Pruritus—Paclitaxel—kidney cancer	0.000373	0.000641	CcSEcCtD
Pentoxifylline—Constipation—Capecitabine—kidney cancer	0.00037	0.000636	CcSEcCtD
Pentoxifylline—Flushing—Doxorubicin—kidney cancer	0.000365	0.000626	CcSEcCtD
Pentoxifylline—Diarrhoea—Paclitaxel—kidney cancer	0.000361	0.00062	CcSEcCtD
Pentoxifylline—Feeling abnormal—Capecitabine—kidney cancer	0.000357	0.000613	CcSEcCtD
Pentoxifylline—Immune system disorder—Doxorubicin—kidney cancer	0.000355	0.00061	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Capecitabine—kidney cancer	0.000354	0.000608	CcSEcCtD
Pentoxifylline—Arrhythmia—Doxorubicin—kidney cancer	0.000351	0.000603	CcSEcCtD
Pentoxifylline—Dizziness—Paclitaxel—kidney cancer	0.000349	0.000599	CcSEcCtD
Pentoxifylline—Urticaria—Capecitabine—kidney cancer	0.000344	0.000591	CcSEcCtD
Pentoxifylline—Abdominal pain—Capecitabine—kidney cancer	0.000342	0.000588	CcSEcCtD
Pentoxifylline—Body temperature increased—Capecitabine—kidney cancer	0.000342	0.000588	CcSEcCtD
Pentoxifylline—Erythema—Doxorubicin—kidney cancer	0.000342	0.000588	CcSEcCtD
Pentoxifylline—Flatulence—Doxorubicin—kidney cancer	0.000337	0.000579	CcSEcCtD
Pentoxifylline—Tension—Doxorubicin—kidney cancer	0.000336	0.000577	CcSEcCtD
Pentoxifylline—Vomiting—Paclitaxel—kidney cancer	0.000336	0.000576	CcSEcCtD
Pentoxifylline—Dysgeusia—Doxorubicin—kidney cancer	0.000335	0.000575	CcSEcCtD
Pentoxifylline—Rash—Paclitaxel—kidney cancer	0.000333	0.000572	CcSEcCtD
Pentoxifylline—Dermatitis—Paclitaxel—kidney cancer	0.000333	0.000571	CcSEcCtD
Pentoxifylline—Nervousness—Doxorubicin—kidney cancer	0.000332	0.000571	CcSEcCtD
Pentoxifylline—Back pain—Doxorubicin—kidney cancer	0.000331	0.000568	CcSEcCtD
Pentoxifylline—Headache—Paclitaxel—kidney cancer	0.000331	0.000568	CcSEcCtD
Pentoxifylline—Muscle spasms—Doxorubicin—kidney cancer	0.000329	0.000565	CcSEcCtD
Pentoxifylline—Vision blurred—Doxorubicin—kidney cancer	0.000322	0.000554	CcSEcCtD
Pentoxifylline—Hypersensitivity—Capecitabine—kidney cancer	0.000319	0.000548	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Doxorubicin—kidney cancer	0.000317	0.000545	CcSEcCtD
Pentoxifylline—Anaemia—Doxorubicin—kidney cancer	0.000316	0.000543	CcSEcCtD
Pentoxifylline—Agitation—Doxorubicin—kidney cancer	0.000314	0.00054	CcSEcCtD
Pentoxifylline—Nausea—Paclitaxel—kidney cancer	0.000314	0.000538	CcSEcCtD
Pentoxifylline—Asthenia—Capecitabine—kidney cancer	0.000311	0.000534	CcSEcCtD
Pentoxifylline—Malaise—Doxorubicin—kidney cancer	0.000309	0.00053	CcSEcCtD
Pentoxifylline—Pruritus—Capecitabine—kidney cancer	0.000306	0.000526	CcSEcCtD
Pentoxifylline—Leukopenia—Doxorubicin—kidney cancer	0.000306	0.000526	CcSEcCtD
Pentoxifylline—Palpitations—Doxorubicin—kidney cancer	0.000302	0.000519	CcSEcCtD
Pentoxifylline—Convulsion—Doxorubicin—kidney cancer	0.000296	0.000509	CcSEcCtD
Pentoxifylline—Diarrhoea—Capecitabine—kidney cancer	0.000296	0.000509	CcSEcCtD
Pentoxifylline—Hypertension—Doxorubicin—kidney cancer	0.000295	0.000507	CcSEcCtD
Pentoxifylline—Myalgia—Doxorubicin—kidney cancer	0.000291	0.0005	CcSEcCtD
Pentoxifylline—Chest pain—Doxorubicin—kidney cancer	0.000291	0.0005	CcSEcCtD
Pentoxifylline—Anxiety—Doxorubicin—kidney cancer	0.00029	0.000498	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000289	0.000497	CcSEcCtD
Pentoxifylline—Discomfort—Doxorubicin—kidney cancer	0.000288	0.000494	CcSEcCtD
Pentoxifylline—Dizziness—Capecitabine—kidney cancer	0.000286	0.000492	CcSEcCtD
Pentoxifylline—Dry mouth—Doxorubicin—kidney cancer	0.000285	0.000489	CcSEcCtD
Pentoxifylline—Confusional state—Doxorubicin—kidney cancer	0.000282	0.000484	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Doxorubicin—kidney cancer	0.000279	0.00048	CcSEcCtD
Pentoxifylline—Oedema—Doxorubicin—kidney cancer	0.000279	0.00048	CcSEcCtD
Pentoxifylline—Infection—Doxorubicin—kidney cancer	0.000277	0.000476	CcSEcCtD
Pentoxifylline—Vomiting—Capecitabine—kidney cancer	0.000275	0.000473	CcSEcCtD
Pentoxifylline—Shock—Doxorubicin—kidney cancer	0.000275	0.000472	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Doxorubicin—kidney cancer	0.000273	0.00047	CcSEcCtD
Pentoxifylline—Rash—Capecitabine—kidney cancer	0.000273	0.000469	CcSEcCtD
Pentoxifylline—Dermatitis—Capecitabine—kidney cancer	0.000273	0.000469	CcSEcCtD
Pentoxifylline—Tachycardia—Doxorubicin—kidney cancer	0.000273	0.000468	CcSEcCtD
Pentoxifylline—Headache—Capecitabine—kidney cancer	0.000271	0.000466	CcSEcCtD
Pentoxifylline—Skin disorder—Doxorubicin—kidney cancer	0.000271	0.000466	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Doxorubicin—kidney cancer	0.00027	0.000464	CcSEcCtD
Pentoxifylline—Anorexia—Doxorubicin—kidney cancer	0.000266	0.000457	CcSEcCtD
Pentoxifylline—Hypotension—Doxorubicin—kidney cancer	0.000261	0.000448	CcSEcCtD
Pentoxifylline—Nausea—Capecitabine—kidney cancer	0.000257	0.000442	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000254	0.000437	CcSEcCtD
Pentoxifylline—Insomnia—Doxorubicin—kidney cancer	0.000253	0.000434	CcSEcCtD
Pentoxifylline—Dyspnoea—Doxorubicin—kidney cancer	0.000249	0.000428	CcSEcCtD
Pentoxifylline—Somnolence—Doxorubicin—kidney cancer	0.000248	0.000426	CcSEcCtD
Pentoxifylline—Dyspepsia—Doxorubicin—kidney cancer	0.000246	0.000422	CcSEcCtD
Pentoxifylline—Decreased appetite—Doxorubicin—kidney cancer	0.000243	0.000417	CcSEcCtD
Pentoxifylline—Constipation—Doxorubicin—kidney cancer	0.000239	0.00041	CcSEcCtD
Pentoxifylline—Feeling abnormal—Doxorubicin—kidney cancer	0.00023	0.000395	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000228	0.000392	CcSEcCtD
Pentoxifylline—Urticaria—Doxorubicin—kidney cancer	0.000222	0.000381	CcSEcCtD
Pentoxifylline—Body temperature increased—Doxorubicin—kidney cancer	0.000221	0.000379	CcSEcCtD
Pentoxifylline—Abdominal pain—Doxorubicin—kidney cancer	0.000221	0.000379	CcSEcCtD
Pentoxifylline—Hypersensitivity—Doxorubicin—kidney cancer	0.000206	0.000353	CcSEcCtD
Pentoxifylline—Asthenia—Doxorubicin—kidney cancer	0.0002	0.000344	CcSEcCtD
Pentoxifylline—Pruritus—Doxorubicin—kidney cancer	0.000198	0.000339	CcSEcCtD
Pentoxifylline—Diarrhoea—Doxorubicin—kidney cancer	0.000191	0.000328	CcSEcCtD
Pentoxifylline—Dizziness—Doxorubicin—kidney cancer	0.000185	0.000317	CcSEcCtD
Pentoxifylline—Vomiting—Doxorubicin—kidney cancer	0.000178	0.000305	CcSEcCtD
Pentoxifylline—Rash—Doxorubicin—kidney cancer	0.000176	0.000302	CcSEcCtD
Pentoxifylline—Dermatitis—Doxorubicin—kidney cancer	0.000176	0.000302	CcSEcCtD
Pentoxifylline—Headache—Doxorubicin—kidney cancer	0.000175	0.0003	CcSEcCtD
Pentoxifylline—Nausea—Doxorubicin—kidney cancer	0.000166	0.000285	CcSEcCtD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	0.000104	0.000371	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FLT1—kidney cancer	0.000104	0.00037	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PAK1—kidney cancer	0.000103	0.000366	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—JUNB—kidney cancer	0.000103	0.000366	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FLT1—kidney cancer	0.000103	0.000365	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PTEN—kidney cancer	0.000102	0.000362	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—KRAS—kidney cancer	0.000101	0.000359	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ITPR2—kidney cancer	9.87e-05	0.000352	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—POMC—kidney cancer	9.78e-05	0.000349	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—POMC—kidney cancer	9.67e-05	0.000345	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—JUNB—kidney cancer	9.62e-05	0.000343	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PAK1—kidney cancer	9.62e-05	0.000343	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—JUNB—kidney cancer	9.5e-05	0.000339	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PAK1—kidney cancer	9.5e-05	0.000339	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—POMC—kidney cancer	9.49e-05	0.000338	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ACY1—kidney cancer	9.28e-05	0.000331	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—PIK3CA—kidney cancer	9.26e-05	0.00033	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF2—kidney cancer	9.25e-05	0.00033	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN2B—kidney cancer	9.21e-05	0.000328	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CTNNA1—kidney cancer	8.95e-05	0.000319	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF1R—kidney cancer	8.94e-05	0.000319	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EIF4EBP1—kidney cancer	8.9e-05	0.000317	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HSPB1—kidney cancer	8.9e-05	0.000317	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—POMC—kidney cancer	8.88e-05	0.000317	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—POMC—kidney cancer	8.78e-05	0.000313	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—RAF1—kidney cancer	8.61e-05	0.000307	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL2—kidney cancer	8.51e-05	0.000303	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF2—kidney cancer	8.4e-05	0.000299	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN2B—kidney cancer	8.36e-05	0.000298	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PSMD7—kidney cancer	8.27e-05	0.000295	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TSC1—kidney cancer	8.27e-05	0.000295	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ANXA1—kidney cancer	8.27e-05	0.000295	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF1R—kidney cancer	8.12e-05	0.000289	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FLT1—kidney cancer	8.01e-05	0.000285	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	7.91e-05	0.000282	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PDHB—kidney cancer	7.89e-05	0.000281	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—POMC—kidney cancer	7.86e-05	0.00028	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF2—kidney cancer	7.86e-05	0.00028	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN2B—kidney cancer	7.83e-05	0.000279	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—RAF1—kidney cancer	7.82e-05	0.000279	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF2—kidney cancer	7.77e-05	0.000277	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN2B—kidney cancer	7.74e-05	0.000276	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL2—kidney cancer	7.72e-05	0.000275	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL2—kidney cancer	7.72e-05	0.000275	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF1R—kidney cancer	7.6e-05	0.000271	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—POMC—kidney cancer	7.55e-05	0.000269	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF1R—kidney cancer	7.51e-05	0.000268	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PAK1—kidney cancer	7.42e-05	0.000265	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JUNB—kidney cancer	7.42e-05	0.000265	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CCBL1—kidney cancer	7.42e-05	0.000264	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HIF1A—kidney cancer	7.36e-05	0.000262	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TSC2—kidney cancer	7.34e-05	0.000262	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—RAF1—kidney cancer	7.32e-05	0.000261	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—RAF1—kidney cancer	7.24e-05	0.000258	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL2—kidney cancer	7.23e-05	0.000258	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PIK3CA—kidney cancer	7.16e-05	0.000255	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL2—kidney cancer	7.15e-05	0.000255	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KDR—kidney cancer	7.04e-05	0.000251	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2—kidney cancer	7.01e-05	0.00025	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—POMC—kidney cancer	6.86e-05	0.000244	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.71e-05	0.000239	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HIF1A—kidney cancer	6.68e-05	0.000238	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TSC2—kidney cancer	6.67e-05	0.000238	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2—kidney cancer	6.57e-05	0.000234	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2—kidney cancer	6.49e-05	0.000231	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KIT—kidney cancer	6.48e-05	0.000231	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APC—kidney cancer	6.48e-05	0.000231	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPAT—kidney cancer	6.43e-05	0.000229	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GLIPR1—kidney cancer	6.43e-05	0.000229	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KDR—kidney cancer	6.39e-05	0.000228	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.35e-05	0.000226	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.29e-05	0.000224	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HIF1A—kidney cancer	6.26e-05	0.000223	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TSC2—kidney cancer	6.24e-05	0.000222	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—MAPK3—kidney cancer	6.21e-05	0.000221	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HIF1A—kidney cancer	6.18e-05	0.00022	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—POMC—kidney cancer	6.17e-05	0.00022	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TSC2—kidney cancer	6.17e-05	0.00022	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—BRAF—kidney cancer	6.09e-05	0.000217	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF2—kidney cancer	6.07e-05	0.000216	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN2B—kidney cancer	6.04e-05	0.000215	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KDR—kidney cancer	5.98e-05	0.000213	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APRT—kidney cancer	5.98e-05	0.000213	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—FH—kidney cancer	5.98e-05	0.000213	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KDR—kidney cancer	5.91e-05	0.000211	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—MAPK1—kidney cancer	5.91e-05	0.000211	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APC—kidney cancer	5.89e-05	0.00021	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KIT—kidney cancer	5.89e-05	0.00021	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF1R—kidney cancer	5.87e-05	0.000209	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.84e-05	0.000208	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—RAF1—kidney cancer	5.66e-05	0.000202	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PIK3CA—kidney cancer	5.65e-05	0.000201	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—MAPK3—kidney cancer	5.64e-05	0.000201	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GPC3—kidney cancer	5.62e-05	0.0002	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—POMC—kidney cancer	5.6e-05	0.0002	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2—kidney cancer	5.58e-05	0.000199	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—KRAS—kidney cancer	5.58e-05	0.000199	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—BRAF—kidney cancer	5.53e-05	0.000197	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KIT—kidney cancer	5.51e-05	0.000196	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APC—kidney cancer	5.51e-05	0.000196	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA2—kidney cancer	5.47e-05	0.000195	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APC—kidney cancer	5.45e-05	0.000194	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KIT—kidney cancer	5.45e-05	0.000194	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—MAPK1—kidney cancer	5.37e-05	0.000191	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALAD—kidney cancer	5.33e-05	0.00019	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—MAPK3—kidney cancer	5.28e-05	0.000188	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—POMC—kidney cancer	5.25e-05	0.000187	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—MAPK3—kidney cancer	5.22e-05	0.000186	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ST3GAL2—kidney cancer	5.2e-05	0.000185	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—POMC—kidney cancer	5.19e-05	0.000185	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—BRAF—kidney cancer	5.18e-05	0.000185	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PIK3CA—kidney cancer	5.13e-05	0.000183	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PIK3CA—kidney cancer	5.13e-05	0.000183	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—BRAF—kidney cancer	5.12e-05	0.000182	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RAF1—kidney cancer	5.09e-05	0.000181	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALDH1A1—kidney cancer	5.08e-05	0.000181	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2—kidney cancer	5.07e-05	0.000181	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—KRAS—kidney cancer	5.07e-05	0.000181	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RELA—kidney cancer	5.07e-05	0.000181	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ERBB2—kidney cancer	5.03e-05	0.000179	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—MAPK1—kidney cancer	5.02e-05	0.000179	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MTOR—kidney cancer	4.97e-05	0.000177	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—MAPK1—kidney cancer	4.96e-05	0.000177	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC5A3—kidney cancer	4.87e-05	0.000174	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PGK1—kidney cancer	4.87e-05	0.000174	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HIF1A—kidney cancer	4.83e-05	0.000172	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TSC2—kidney cancer	4.82e-05	0.000172	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CA—kidney cancer	4.8e-05	0.000171	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—LDHB—kidney cancer	4.78e-05	0.00017	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—KRAS—kidney cancer	4.75e-05	0.000169	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CA—kidney cancer	4.74e-05	0.000169	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—KRAS—kidney cancer	4.69e-05	0.000167	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1B—kidney cancer	4.66e-05	0.000166	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CA—kidney cancer	4.66e-05	0.000166	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RAF1—kidney cancer	4.62e-05	0.000165	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KDR—kidney cancer	4.62e-05	0.000165	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RELA—kidney cancer	4.6e-05	0.000164	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ERBB2—kidney cancer	4.57e-05	0.000163	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2—kidney cancer	4.56e-05	0.000163	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MTOR—kidney cancer	4.51e-05	0.000161	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCND1—kidney cancer	4.45e-05	0.000159	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—JUN—kidney cancer	4.44e-05	0.000158	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CTNNB1—kidney cancer	4.4e-05	0.000157	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CA—kidney cancer	4.36e-05	0.000155	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RAF1—kidney cancer	4.33e-05	0.000154	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RELA—kidney cancer	4.31e-05	0.000154	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CA—kidney cancer	4.31e-05	0.000154	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTEN—kidney cancer	4.29e-05	0.000153	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ERBB2—kidney cancer	4.28e-05	0.000153	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RAF1—kidney cancer	4.28e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KIT—kidney cancer	4.26e-05	0.000152	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RELA—kidney cancer	4.26e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APC—kidney cancer	4.26e-05	0.000152	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1B—kidney cancer	4.23e-05	0.000151	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ERBB2—kidney cancer	4.23e-05	0.000151	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MTOR—kidney cancer	4.22e-05	0.000151	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MTOR—kidney cancer	4.17e-05	0.000149	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA9—kidney cancer	4.14e-05	0.000148	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2—kidney cancer	4.14e-05	0.000148	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—MAPK3—kidney cancer	4.08e-05	0.000145	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—POMC—kidney cancer	4.05e-05	0.000144	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.05e-05	0.000144	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCND1—kidney cancer	4.04e-05	0.000144	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—JUN—kidney cancer	4.03e-05	0.000144	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—BRAF—kidney cancer	4e-05	0.000143	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CTNNB1—kidney cancer	4e-05	0.000143	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1B—kidney cancer	3.96e-05	0.000141	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1B—kidney cancer	3.92e-05	0.00014	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTEN—kidney cancer	3.9e-05	0.000139	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2—kidney cancer	3.88e-05	0.000138	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—MAPK1—kidney cancer	3.88e-05	0.000138	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—kidney cancer	3.88e-05	0.000138	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2—kidney cancer	3.83e-05	0.000137	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCND1—kidney cancer	3.78e-05	0.000135	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—JUN—kidney cancer	3.77e-05	0.000135	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CTNNB1—kidney cancer	3.75e-05	0.000133	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCND1—kidney cancer	3.74e-05	0.000133	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—JUN—kidney cancer	3.73e-05	0.000133	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CA—kidney cancer	3.71e-05	0.000132	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CTNNB1—kidney cancer	3.7e-05	0.000132	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK3—kidney cancer	3.67e-05	0.000131	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—KRAS—kidney cancer	3.66e-05	0.000131	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTEN—kidney cancer	3.65e-05	0.00013	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTEN—kidney cancer	3.61e-05	0.000129	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—kidney cancer	3.57e-05	0.000127	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CRABP1—kidney cancer	3.52e-05	0.000126	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—kidney cancer	3.52e-05	0.000125	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK1—kidney cancer	3.49e-05	0.000124	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CA—kidney cancer	3.37e-05	0.00012	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RAF1—kidney cancer	3.34e-05	0.000119	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK3—kidney cancer	3.33e-05	0.000119	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RELA—kidney cancer	3.33e-05	0.000119	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ERBB2—kidney cancer	3.31e-05	0.000118	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—kidney cancer	3.3e-05	0.000118	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KRAS—kidney cancer	3.3e-05	0.000117	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ITPR2—kidney cancer	3.28e-05	0.000117	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MTOR—kidney cancer	3.26e-05	0.000116	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—kidney cancer	3.26e-05	0.000116	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—kidney cancer	3.24e-05	0.000115	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK1—kidney cancer	3.17e-05	0.000113	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK3—kidney cancer	3.12e-05	0.000111	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK3—kidney cancer	3.08e-05	0.00011	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1B—kidney cancer	3.06e-05	0.000109	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—kidney cancer	3.03e-05	0.000108	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CA—kidney cancer	3.03e-05	0.000108	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.02e-05	0.000108	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—kidney cancer	3e-05	0.000107	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2—kidney cancer	3e-05	0.000107	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KRAS—kidney cancer	2.99e-05	0.000107	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTT1—kidney cancer	2.99e-05	0.000106	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ACHE—kidney cancer	2.99e-05	0.000106	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK1—kidney cancer	2.97e-05	0.000106	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK1—kidney cancer	2.93e-05	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—kidney cancer	2.93e-05	0.000104	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCND1—kidney cancer	2.92e-05	0.000104	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JUN—kidney cancer	2.91e-05	0.000104	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CTNNB1—kidney cancer	2.89e-05	0.000103	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SCARB1—kidney cancer	2.83e-05	0.000101	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTEN—kidney cancer	2.82e-05	0.0001	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KRAS—kidney cancer	2.8e-05	9.99e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS1—kidney cancer	2.8e-05	9.98e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KRAS—kidney cancer	2.77e-05	9.87e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CA—kidney cancer	2.75e-05	9.8e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PSMD7—kidney cancer	2.75e-05	9.78e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—kidney cancer	2.66e-05	9.48e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—BCHE—kidney cancer	2.6e-05	9.27e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CA—kidney cancer	2.58e-05	9.18e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC5A5—kidney cancer	2.57e-05	9.16e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—kidney cancer	2.55e-05	9.07e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CA—kidney cancer	2.54e-05	9.07e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—kidney cancer	2.49e-05	8.88e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC2A1—kidney cancer	2.48e-05	8.85e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—kidney cancer	2.46e-05	8.77e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.41e-05	8.58e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK3—kidney cancer	2.41e-05	8.58e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—kidney cancer	2.34e-05	8.35e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK1—kidney cancer	2.29e-05	8.17e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KRAS—kidney cancer	2.16e-05	7.71e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.1e-05	7.49e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTP1—kidney cancer	2.07e-05	7.38e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CA—kidney cancer	1.99e-05	7.09e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCB1—kidney cancer	1.96e-05	6.99e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—kidney cancer	1.92e-05	6.86e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTM1—kidney cancer	1.9e-05	6.78e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.8e-05	6.43e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.48e-05	5.28e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—POMC—kidney cancer	1.34e-05	4.79e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—kidney cancer	1.07e-05	3.82e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTEN—kidney cancer	9.36e-06	3.33e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CA—kidney cancer	6.6e-06	2.35e-05	CbGpPWpGaD
